178 related articles for article (PubMed ID: 24139926)
1. Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies.
Hu Y; Li L; Li W; Xu H; He P; Yan X; Dai H
Int J Antimicrob Agents; 2013 Dec; 42(6):492-6. PubMed ID: 24139926
[TBL] [Abstract][Full Text] [Related]
2. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
[TBL] [Abstract][Full Text] [Related]
3. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden C
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S71-5. PubMed ID: 17698326
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study.
Paulsson M; Granrot A; Ahl J; Tham J; Resman F; Riesbeck K; Månsson F
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1187-1196. PubMed ID: 28110415
[TBL] [Abstract][Full Text] [Related]
6. Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia.
Paul M; Leibovici L
Lancet Infect Dis; 2005 Apr; 5(4):192-3; discussion 193-4. PubMed ID: 15792730
[No Abstract] [Full Text] [Related]
7. Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum.
Traugott KA; Echevarria K; Maxwell P; Green K; Lewis JS
Pharmacotherapy; 2011 Jun; 31(6):598-608. PubMed ID: 21923444
[TBL] [Abstract][Full Text] [Related]
8. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis.
Safdar N; Handelsman J; Maki DG
Lancet Infect Dis; 2004 Aug; 4(8):519-27. PubMed ID: 15288826
[TBL] [Abstract][Full Text] [Related]
9. Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?
Wu PF; Lin YT; Wang FD; Yang TC; Fung CP
Infection; 2018 Jun; 46(3):365-373. PubMed ID: 29556979
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of appropriate empiric combination versus monotherapy for Pseudomonas aeruginosa bacteremia.
Bowers DR; Liew YX; Lye DC; Kwa AL; Hsu LY; Tam VH
Antimicrob Agents Chemother; 2013 Mar; 57(3):1270-4. PubMed ID: 23263001
[TBL] [Abstract][Full Text] [Related]
11. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
12. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic therapy and clinical outcomes of Pseudomonas aeruginosa (PA) bacteraemia.
Tan SH; Teng CB; Ng TM; Lye DC
Ann Acad Med Singap; 2014 Nov; 43(11):526-34. PubMed ID: 25523856
[TBL] [Abstract][Full Text] [Related]
14. Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Kim J; Kang CI; Baek JY; Cho SY; Kim SH; Ko KS; Chung DR; Peck KR; Song JH
Int J Antimicrob Agents; 2014 Apr; 43(4):391-3. PubMed ID: 24637223
[No Abstract] [Full Text] [Related]
15. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
16. Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Abdel Fattah M; Haquin J; MacGowan A; Grier S; Gibbs J; Chazan B; Yanovskay A; Ami RB; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; Morales I; Oliver A; Ruiz de Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez LM; Gonzalez-Barbera EM; Alfaro IG; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
J Antimicrob Chemother; 2021 Jul; 76(8):2172-2181. PubMed ID: 33993273
[TBL] [Abstract][Full Text] [Related]
17. Impact of Pseudomonas aeruginosa bacteraemia in a tertiary hospital: Mortality and prognostic factors.
Callejas-Díaz A; Fernández-Pérez C; Ramos-Martínez A; Múñez-Rubio E; Sánchez-Romero I; Vargas Núñez JA
Med Clin (Barc); 2019 Feb; 152(3):83-89. PubMed ID: 29885868
[TBL] [Abstract][Full Text] [Related]
18. Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection.
Joo EJ; Kang CI; Ha YE; Park SY; Kang SJ; Wi YM; Lee NY; Chung DR; Peck KR; Song JH
Infection; 2011 Aug; 39(4):309-18. PubMed ID: 21594653
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
Chen SC; Lawrence RH; Byth K; Sorrell TC
Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
[TBL] [Abstract][Full Text] [Related]
20. Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohort.
Peña C; Suarez C; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez F; Tubau F; Oliver A; Martínez-Martínez L;
Clin Infect Dis; 2013 Jul; 57(2):208-16. PubMed ID: 23580739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]